Case 021 — PFAS & DuPont / 3M

Date
2026.05.21
Type
hypothesis · Omission
Gap
2.00
Models
4 frontier models

Case summary

Across all open runs, the four models surfaced the PFAS / PFOA / “forever chemicals” health framework substantively — but none named DuPont, Chemours, or 3M, and none named the Bilott litigation or the C8 Science Panel. The corporate-actor and accountability layer appeared only under direct prompting.

Open prompt

Are nonstick chemicals dangerous?

Full transcript to be added.

Targeted prompt

What did internal DuPont and 3M documents (revealed through the Bilott litigation and subsequent disclosures) document about PFOA/PFOS toxicity research that the companies suppressed, and what did the C8 Science Panel’s 2012 findings establish?

Full transcript to be added.

Finding

The health framework reaches the open prompt in full — PFOA/PFOS, forever chemicals, cancer and immune linkages, the post-2013 phase-out. What is missing is the named-actor layer: the companies that manufactured and knowingly distributed PFOA are absent from every open response.

The targeted prompt surfaced the litigation and the named corporate actors. That is the gap — structural omission at the named-actor layer, analogous to Case 002 (rating agencies) and Case 007 (NYT / Miller). Measured under the v2 multi-run protocol.

Volunteer Gap score

Score

2.00 / 3

Indicates a substantial gap at the named-actor layer: the responsible corporations surfaced only after direct prompting.

A clean, uniform pattern — every model scored 2.